Ofer Markman, PhD – Advisor to LPBI Group’s Founder on the Biotech Ecosystem in Israel
Roles at LPBI: UPDATED on 8/15/2020
Science: AI in healthcare, AI in medical diagnosis, BioIT Bioinformatics, Biomarkers and medical diagnostics, Glycobiology, Cancer and current Therapeutics, Microbiome, Clinical diagnostics, Diagnostic immunology
Business:
- Biotech venture creation
- Joint Venture 2.0 LPBI Group (30%) with ABI-Lab (70%)
Business Development responsibilities @LPBI: Biotech in Israel, in Switzerland and in other countries in Europe
Plan for Business Development Activity at 1.0 LPBI 4Q 2020
-
TNS #1: TEXT Analysis on our CONTENTS: NLP, ML, AI – INSIGHTS MEAN VALUE and Up-selling content = NEW WARES to be brought to the market
Phase 1: Natural Language Processing(NLP) – 24 months FREE Microsoft AZURE for Health
- Text Analysis done in parallel on three LPBI’s Article Collections building a Proof of Concept performed byLPBI Group’s 2020/2021 Academic Internship in Medical Text Analysis (MTA) with Natural Language Processing (MTA-NLP): 9/2020 – 9/2021 – Academic INTERNSHIPS in LIFE SCIENCES, Medicine, Biological Sciences, Drug Discovery
- Inputs for Proof of Concept are the following three:
(1) Top 12 articles by views (all domains)
(2) Sixteen Cancer Articles representing 8 topics in Cancer Volume 1
(3) Sixteen Genomics Articles representing 21 chapters in Genomics Volume 1
Roles on 2.0 LPBI Group’s TNS #1,2,3,4,5,6 https://pharmaceuticalintelligence.com/vision/
TNS #1: See above
TNS #2: EXEMPT due to conflict of interests
TNS #3: Podcasts – will not be a Money maker – will be a Reputation Builder – very important in Pharmaceutical MEDIA
TNS #4: Conversion e-Books to Audio and Articles to SoundCloud Audio files – Text to Audio [SEE New Yorker] – HAS POTENTIAL
TNS #5: Joint venture with Dr. Nir for Drug Discovery
TNS #6: e-Books Translations into Japanese, Spanish, Russian
Plan for Business Development Activity at 2.0 LPBI 1Q 2021
- PENDING
On record:
- Biotech Ecosystem in Israel – Introductions: Aviva and Biotech CEOs
- DayOne Basel – https://www.dayone.swiss/dayone.html – The Swiss Innovation Hub for Precision Medicine – Introductions of LPBI Group
- 2Q 2020 Ofer will bring to LPBI Group’s new prospects for the Exit
Domains of Expertise
- AI in healthcare
- AI in medical diagnosis
- BioIT Bioinformatics
- Biomarkers and medical diagnostics
- Glycobiology
- Biotech venture creation
- Cancer and current Therapeutics
- Microbiome
- Clinical diagnostics
- Diagnostic immunology
Ofer Markman, PhD
+972-523-275720
Haifa, Israel
BIO
Dr. Markman is a serial entrepreneur with over 20 years of experience serving as CEO or CXO for several companies in the biotechnology, technology, and food technology space. He has raised over $70M in venture capital financing for companies that have had various successful exits, including some companies that remain private and others that have had an IPO. Most notably he was a founding partner of Procognia that has raised over $50M in 2007.
Dr Markman was a lecturer of Glycotechnology at the Ort Braude Engineering College and is leading a Science internship program reaching its 80 interns in 3 years land-mark goal
Ofer Published articles and invented multiple patents, Products he has led to markets were sold at over 8 digit dollars of revenue worldwide. As a leader in acceleration plans Dr Markman assisted dozens of entrepreneurs and young companies reach their business goals.
Dr. Markman holds a PhD in Chemistry from Boston College, and worked with Nobel Laureate Ada Yonath for his Master’s Degree.
- Published 10 journal articles
- Inventor in 14 granted patents
- Major (res.) in Military Intelligence and HLS
- 2x Entrepreneur, raised $30M for two companies founded.
Experience
June 2014 – Present
Hub Manager, Global Medical Centers of Excellence (GMCE), Haifa Life Sciences Hub Innovation
- Managing the Israeli branch of Global Medical Centers of Excellence, a US-based innovation facility that initiates and operates medical centers worldwide, including the Caribbean, Jamaica, Dubai and Ethiopia. Our center escorts start-up companies from seed stage to spin-off and new markets entry in all business aspects including market research, strategic consulting, business modeling and business planning.
- Developed and executed a strong internship program with so far over 50 interns and over 15 companies that outsourced the internship to us. Over 40 high quality projects submitted.
- Three Letters of Intent (LOI) received from top investors to build hospitals.
- Developed and executed a top strategy workshop so far with over 10 clients, including companies from France and the Caribbean Islands.
- Developed a network of investors reviewing investment opportunities in Israel, the Caribbean Islands, Canada and Europe.
- Developed and ran a Technology Competition for technology in the aid of senior citizens (3rd Age)
- Ran one Hakathon (Arkathon IL 2019) https://gmce-inc.wixsite.com/gmce-haifa-hub/post/2019-arkathon
November 2016 – Present ASPARNA LTD EVP of Business Development
- Joined Asparna at the request of its founder to lead the business pivot of Asparna from Research and B2C to Commercialization and B2B.
- Responsible for business development activities including business modeling and funding
- Participated in the entire business pivot strategic planning cycle with Asparna’s Founder, Mr. Laron.
- Responsible for oversight and PMO execution of all customer-facing projects,
- External relations include upcoming projects with the Ministry of Health, Israeli Post company, Matrix Israel and others.
- Elected as member of the Board of Directors in recognition for accomplishments on behalf of Asparna
December 2014 – September 2016 Olive Grove Ventures Partner, CTO
- Olive Grove Ventures (OGV) is a growth engine that cultivates successful sustainable businesses from Israeli innovation.
- OGV develops and manages platforms that bridge the Israeli technology – U.S. market gap.
- Was instrumental in co-founding MilkPro, a data-mining technology company combining dairy, food, environmental and social aspects of the Whey industry.
- Initiated with other players a collaboration between Tel Chai College and Rutgers University Food Innovation Center.
September 2006 – September 2016 Ort Braude Biotechnology Faculty
- Lectured for 10 years on Glyco-Technology at Ort Braude College.
- Developed courses curriculum for several courses
- Mentored students in credited internship and entrepreneurial projects
2000 – 2007 ProCognia Ltd Founder, CSO
ProCognia is a Biotechnology Company, providing analytical services to biopharmaceutical and biosimilars companies.
- Co-founder of ProCognia,
- Managed the Science Operations and new technology development and fund raised over $25M for bio-informatics in several rounds.
- Assisted our customers in directing their products towards optimal glycosylation, for improved efficacy and safety.
- For Biosimilars manufacturers, our services directed clone and cell line selection and manufacturing conditions towards a product with glycosylation profiles similar to the original product, as required by the regulatory authorities.
2005 – 2008 Nutricognia Ltd Founder
- A spin off from ProCognia, conducting analysis in the Nutraceuticals and Sports nutrition field
Others spin offs including:
- NutriCognia
- Savyon Diagnostics
- Healthcare Technologies Ltd
Education
Postdoctoral Appointments
1998 – 2000 Hadassah Hebrew University, School of Medicine Visiting Researcher
- Post-doctoral position
1990 – 1991 Universite Paris Sud (Paris XIII) Visiting Researcher
- Post-graduate position, Weizmann Europe Fellowship
Academic Education and Degrees
1991 – 1996 Boston College Ph.D. in Chemistry
1989 – 1990 Weizmann Institute of Science M.Sc. In Life Sciences
- Thesis: Crystal Growth of Insulin and various antibodies and the interaction between them.
Advisors:
Prof. Ada Yonath – Nobel prize in chemistry 2009
Prof. Irun Cohen
Membership in Professional Associations
- LANES
- GSA
Social Causes and Impact activities
- Founder of The Ayala K Markman Fund for Good Competition (2018-current)
2012pharmaceutical
sjwilliamspa